Kistler-Tiffany Companies’s Guardant Health GH Stock Holding History

Kistler-Tiffany Companies’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-131	Closed	-$9K	–	769
2022 Q1	$9K	Hold	131	–	–	﹤0.01%	605
2021 Q4	$13K	Hold	131	–	–	﹤0.01%	557
2021 Q3	$16K	Sell	131 -39	-23%	-$4.63K	﹤0.01%	530
2021 Q2	$21K	Hold	170	–	–	﹤0.01%	483
2021 Q1	$26K	Hold	170	–	–	0.01%	418
2020 Q4	$22K	Hold	170	–	–	0.01%	406
2020 Q3	$19K	Hold	170	–	–	0.01%	395
2020 Q2	$14K	Hold	170	–	–	0.01%	405
2020 Q1	$13K	Hold	170	–	–	﹤0.01%	409
2019 Q4	$13K	Hold	170	–	–	﹤0.01%	415
2019 Q3	$11K	Buy	170 +70	+70%	+$6.17K	﹤0.01%	436
2019 Q2	$9K	Hold	100	–	–	﹤0.01%	451
2019 Q1	$8K	Buy	+100	New	+$5.54K	﹤0.01%	457

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Kistler-Tiffany Companies's GH Position: Q2 2022 in Review

Kistler-Tiffany Companies sold out of Guardant Health (GH) in Q2 2022, closing a stake of 131 shares — an estimated $9K sold.

Kistler-Tiffany Companies first reported a position in GH in Q1 2019 and held it in 13 quarters. The position peaked at $26K in Q1 2021. 331 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Kistler-Tiffany Companies reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Kistler-Tiffany Companies sold 131 Guardant Health shares in Q2 2022, an estimated $9K.
Kistler-Tiffany Companies first reported a position in Guardant Health in Q1 2019 and held it in 13 quarters.
Kistler-Tiffany Companies's Guardant Health position peaked at $26K in Q1 2021.
331 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2022, filed 8 Aug 2022.